Results 131 to 140 of about 19,061 (206)

Outcome measures in prehabilitation interventions for total hip and knee arthroplasty: A scoping review. [PDF]

Clin Rehabil
Burgess N, Voelker SN, Phillips B, Graco M, Berney S, Denehy L, Edbrooke L.   +6 more
europepmc   +1 more source

Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice

, 2019
Р. A. Balunov, A. N. Khitrov
openalex   +2 more sources

Correction: De Novo Cost‑Effectiveness Model Framework for Nonalcoholic Steatohepatitis-Modeling Approach and Validation. [PDF]

Pharmacoeconomics
Gal P, Feldmajer G, Augusto M, Gani R, Hook E, Bullement A, Philips Z, Smith I.   +7 more
europepmc   +1 more source

Developing a value assessment index system of anti-tumour commercial Chinese polyherbal preparation in China: a modified Delphi study. [PDF]

Front Pharmacol
Xia T, Hu M, Luo C, Yang M, Chu M, Xiang X, Zhang Z.   +6 more
europepmc   +1 more source

Publisher Correction: Pricing for Multi-Indication Drugs in the Italian Regulatory Context. [PDF]

Pharmacoecon Open
Ursino MG, Milano A, De Angelis FV, Alessi E, Trotta F.   +4 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain. [PDF]

Pharmacoecon Open
Romero Jiménez RM, Herranz Pinto P, Campos Domínguez M, Bellmunt A, Vidal-Vilar N, Fortes Soto MDP, De Lossada Juste A.   +6 more
europepmc   +1 more source

PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION

, 2015
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva   +3 more
openalex   +2 more sources

Pharmacoeconomic evaluation of chronic kidney disease patients: a study on cost of illness

, 2020
Sarada Sheethal Y, C.R. Esther, Syed Sabiha Sultana, M Mounika, Dileep Kumar T, Kiran Gangarapu   +5 more
openalex   +1 more source

Correction: Health-Related Quality-of-Life Outcomes of Very Preterm or Very Low Birth Weight Adults: Evidence From an Individual Participant Data Meta-Analysis. [PDF]

Pharmacoeconomics
Bolbocean C, van der Pal S, van Buuren S, Anderson PJ, Bartmann P, Baumann N, Cheong JLY, Darlow BA, Doyle LW, Evensen KAI, Horwood J, Indredavik MS, Johnson S, Marlow N, Mendonça M, Ni Y, Wolke D, Woodward L, Verrips E, Petrou S.   +19 more
europepmc   +1 more source

HP3 PHARMACOECONOMIC EDUCATION AT NON-US COLLEGES OF PHARMACY

, 2004
ED Nwokeji, Karen L. Rascati
openalex   +1 more source